victor c. kok
Asia University
Taichung, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
Asia University
Taichung, Taiwan
Review Editor
Cancer Molecular Targets and Therapeutics
National and Kapodistrian University of Athens
Athens, Greece
Review Editor
Cancer Molecular Targets and Therapeutics
Columbia University Irving Medical Center, Columbia University
New York, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Cyprus
Nicosia, Cyprus
Review Editor
Cancer Molecular Targets and Therapeutics
International Agency For Research On Cancer (IARC)
Lyon, France
Review Editor
Cancer Molecular Targets and Therapeutics
Agenus (United States)
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Albert Einstein College of Medicine
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Medical Oncology, School of Medicine, Sapporo Medical University
Sapporo, Japan
Review Editor
Cancer Molecular Targets and Therapeutics
Indo-Soviet Friendship College of Pharmacy
Moga, India
Review Editor
Cancer Molecular Targets and Therapeutics
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Somaiya Vidyavihar University
Mumbai, India
Review Editor
Cancer Molecular Targets and Therapeutics
İnönü University
Malatya, TĂĽrkiye
Review Editor
Cancer Molecular Targets and Therapeutics
National and Kapodistrian University of Athens
Athens, Greece
Review Editor
Cancer Molecular Targets and Therapeutics
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy
Cagliari, Italy
Review Editor
Cancer Molecular Targets and Therapeutics